WinwinGPT is coming soon! Join the waitlist now!

Aclarion inc

US StockHealth Care

ACON AI Analysis Overview

Keys for Bullish View

  • Value≥4
  • Dividend≥2

Analysis Conclusion

With insufficient quarterly financial data released by the company, we're unable to provide a rating.

ACON Current Performance

1.01%

Aclarion inc

0.37%

Avg of Sector

0.74%

S&P500

Top 10 High Relevance to ACON

  • NEPH Nephros inc
    Value 3Trend 1Swing Trading 2Whale Interest 3Dividend 1
    See more

ACON Profile

Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.

Price of ACON